Semaglutide sodium is a compound utilized in managing type 2 diabetes. It functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, regulating blood sugar levels by enhancing insulin secretion, inhibiting glucagon secretion, and delaying gastric emptying. Administered via alternative routes, it effectively controls glycemic levels and diminishes the risk of cardiovascular incidents.